SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (577)7/11/1999 4:24:00 PM
From: Mike McFarland  Read Replies (1) of 4474
 
Thread...fyi I received the minutes of the annual
meeting do not have anything interesting in them
...too bad.

Here is a summary regarding Hoechst/Ariad genomics,
old information, but us die hard Ariad investors like
to wallow in this stuff as we watch our stock slowly
decend into oblivion...
messages.yahoo.com
(microarray spotting and optical scanning instrumentation and
software from Molecular Dynamics, matched reagents and consumables
from Amersham Pharmacia Biotech, designed to help scientists measure
gene expression.....licensed Incyte's LifeSeq gene sequence and
expression database.....licensed from Pangea computational tools
that allow more rapid and accurate clustering and alignment of
Expressed Sequence Tags (ESTs) within large databases....apparently
they also licenced 'SeqStore'--from Oxford Molecular for the analysis
of DNA and protein sequence data....)

add to that
January 14, 1999 — Affymetrix, Inc., (NASDAQ: AFFX) and
Hoechst Marion Roussel, Inc. announced today that they have
entered into an EasyAccess-Gold GeneChip probe array supply
agreement.

Like I said, old news, just 'refreshing' the screen.

...a couple job openings at the Genomics center
genomejobs.com
lab-robotics.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext